DK413588A - Vaevsfaktor-inhibitor (tfi) og fremgangmsaade til fresmtilling heraf - Google Patents

Vaevsfaktor-inhibitor (tfi) og fremgangmsaade til fresmtilling heraf

Info

Publication number
DK413588A
DK413588A DK413588A DK413588A DK413588A DK 413588 A DK413588 A DK 413588A DK 413588 A DK413588 A DK 413588A DK 413588 A DK413588 A DK 413588A DK 413588 A DK413588 A DK 413588A
Authority
DK
Denmark
Prior art keywords
tfi
presentation
procedures
tissue factor
factor inhibitor
Prior art date
Application number
DK413588A
Other languages
English (en)
Other versions
DK174522B1 (da
DK413588D0 (da
Inventor
Jr George John Broze
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22137642&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK413588(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Washington filed Critical Univ Washington
Publication of DK413588D0 publication Critical patent/DK413588D0/da
Publication of DK413588A publication Critical patent/DK413588A/da
Application granted granted Critical
Publication of DK174522B1 publication Critical patent/DK174522B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198804135A 1987-07-23 1988-07-22 Fremgangsmåde til isolering af vævsfaktorinhibitor (TFI) og anvendelse af en således opnået vævsfaktorinhibitor til fremstilling af et antithrombotisk lægemiddel DK174522B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7736687A 1987-07-23 1987-07-23
US7736687 1987-07-23

Publications (3)

Publication Number Publication Date
DK413588D0 DK413588D0 (da) 1988-07-22
DK413588A true DK413588A (da) 1989-01-24
DK174522B1 DK174522B1 (da) 2003-05-12

Family

ID=22137642

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804135A DK174522B1 (da) 1987-07-23 1988-07-22 Fremgangsmåde til isolering af vævsfaktorinhibitor (TFI) og anvendelse af en således opnået vævsfaktorinhibitor til fremstilling af et antithrombotisk lægemiddel

Country Status (14)

Country Link
US (3) US6534276B1 (da)
EP (1) EP0300988A3 (da)
JP (1) JP2781391B2 (da)
KR (1) KR900007261B1 (da)
AU (1) AU604138B2 (da)
BR (1) BR1100464A (da)
CA (1) CA1338122C (da)
DK (1) DK174522B1 (da)
FI (1) FI97298C (da)
IL (1) IL87172A (da)
NO (1) NO174776C (da)
NZ (1) NZ225534A (da)
PT (1) PT88075B (da)
ZA (2) ZA885371B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co cDNA of human tissue factor inhibitor
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
ATE135585T1 (de) * 1990-08-27 1996-04-15 Monsanto Co Anticoagulatorische zusammensetzung aus laci und sulfatierten polysacchariden
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
KR100443572B1 (ko) * 2002-05-29 2004-08-09 광양청매실농원영농조합법인 매실 농축액 제조방법
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
EP2311432B1 (en) 2002-06-07 2014-12-24 Dyax Corporation Modified kunitz domain polypeptides and their use for reducing ischemia or the onset of a systemic inflammatory response associated with a surgical procedure
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
DK1981519T3 (da) 2005-12-29 2018-02-19 Dyax Corp Proteaseinhibering
WO2007092607A2 (en) * 2006-02-09 2007-08-16 Genetech, Inc. Treatment of hemorrhagic viral infections using a tissue factor inhibitor
WO2009026334A2 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
EP3115469B1 (en) * 2007-11-19 2020-04-29 Celera Corporation Lung cancer markers and uses thereof
JP2013516389A (ja) 2009-01-06 2013-05-13 ダイアックス コーポレーション カリクレイン阻害剤による粘膜炎治療
EP3459564B1 (en) 2010-01-06 2021-10-27 Takeda Pharmaceutical Company Limited Plasma kallikrein binding proteins
JP2014506257A (ja) 2011-01-06 2014-03-13 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
AU2015235967B2 (en) 2014-03-27 2020-10-22 Takeda Pharmaceutical Company Limited Compositions and methods for treatment of diabetic macular edema
JP7003354B2 (ja) 2015-12-11 2022-03-04 武田薬品工業株式会社 遺伝性血管性浮腫の発作を治療するための血漿カリクレイン阻害薬およびその用途
JP2023510854A (ja) 2020-01-13 2023-03-15 武田薬品工業株式会社 小児遺伝性血管性浮腫発作を治療するための血漿カリクレイン阻害剤及びその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
US5223427A (en) * 1987-03-31 1993-06-29 The Scripps Research Institute Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
JPH02501263A (ja) * 1987-06-12 1990-05-10 マウント　サイナイ　スクール　オブ　メディシン　オブ　ザ　シティー　ユニバーシティー　オブ　ニューヨーク ヒトの組織因子のクローニングと形質発現
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor

Also Published As

Publication number Publication date
ZA885370B (en) 1989-10-25
IL87172A0 (en) 1988-12-30
NO174776C (no) 1994-07-06
FI883477L (fi) 1989-01-24
NO883271L (no) 1989-01-24
ZA885371B (en) 1989-04-26
FI97298C (fi) 1996-11-25
FI883477A0 (fi) 1988-07-22
US6534276B1 (en) 2003-03-18
DK174522B1 (da) 2003-05-12
KR900007261B1 (en) 1990-10-06
AU604138B2 (en) 1990-12-06
BR1100464A (pt) 2000-02-08
PT88075B (pt) 1995-06-30
IL87172A (en) 1994-12-29
PT88075A (pt) 1989-07-31
EP0300988A3 (en) 1990-04-11
DK413588D0 (da) 1988-07-22
AU1928688A (en) 1989-02-02
JP2781391B2 (ja) 1998-07-30
KR890001581A (ko) 1989-03-27
JPS6447799A (en) 1989-02-22
US20040265981A1 (en) 2004-12-30
US20030166194A1 (en) 2003-09-04
US7060805B2 (en) 2006-06-13
NO174776B (no) 1994-03-28
US6806360B2 (en) 2004-10-19
NZ225534A (en) 1991-02-26
NO883271D0 (no) 1988-07-22
FI97298B (fi) 1996-08-15
EP0300988A2 (en) 1989-01-25
CA1338122C (en) 1996-03-05

Similar Documents

Publication Publication Date Title
DK413588D0 (da) Vaevsfaktor-inhibitor (tfi) og fremgangmsaade til fresmtilling heraf
DK242389A (da) Hydroxamatderivater og fremgangsmaade til fremstilling deraf
DK59991D0 (da) Ikke-peptid-renininhibitorer og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende en saadan inhibitor
DK376986A (da) Di-tert-butylphenol-forbindelser og fremgangsmaade til fremstilling heraf
DK491087D0 (da) Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf
DK159288D0 (da) Saccharidblanding og fremgangsmaade til fremstilling deraf
DK69989A (da) Benzodioxolderivater og fremgangsmaade til fremstilling deraf
DK1693A (da) Pyranobenzoxadiazolderivat og fremgangsmaade til fremstilling deraf
DK202989A (da) Antitumormidler og fremgangsmaade til fremstilling deraf
DK303887A (da) Dopamin-beta-hydroxylaseinhibitorer og fremgangsmaade til fremstilling deraf
DK397788D0 (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
DK251087D0 (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
DK585988A (da) Isopolypeptider og fremgangsmaade til fremstilling deraf
DK515686D0 (da) Dopamin-beta-hydroxylase-inhibitorer og fremgangsmaade til fremstillingderaf
DK487688D0 (da) Benzofuranderivater og fremgangsmaade til fremstilling deraf
DK265288D0 (da) Oximino-ether-forbindelser og fremgangsmaade til fremstilling deraf
DK624588A (da) 4-demethoxy-anthracyclin-derivater og fremgangsmaade til fremstilling deraf
DK129689A (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
DK659189A (da) Benzamidderivat og fremgangsmaade til fremstilling heraf
DK665188D0 (da) Undersoegelsesmetode for antigenbinding og forbindelser til anvendelse herved
DK319188D0 (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf
DK564188D0 (da) Fremgangsmaade og anlaeg til kompostering
DK556589D0 (da) Ikke-reverterende levende shigellavaccine og fremgangsmaade til fremstilling heraf
DK335288D0 (da) Peptolidderivater og fremgangsmaade til fremstilling deraf
DK528989A (da) Vaevsplasminogenaktivator-(t-pa)-muteiner og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
PUP Patent expired